middle.news

Hydralyte USA Accelerates Sales Growth with Fifth Straight Month of EBITDA Gains

9:58am on Thursday 19th of June, 2025 AEST Healthcare
Read Story

Hydralyte USA Accelerates Sales Growth with Fifth Straight Month of EBITDA Gains

9:58am on Thursday 19th of June, 2025 AEST
Key Points
  • May 2025 net sales reached US$308,000, up 34% from April
  • Fifth consecutive month of EBITDA loss reduction
  • Gross margin sustained at a robust 66.5%
  • Cash reserves stand at US$1.9 million as of mid-June
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about The Hydration Pharmaceuticals Company (ASX:HPC)
OPEN ARTICLE